My very dear friend and mentor Dr he in rein Wald invited me as a guest to his amazing conference at Fulda.
Here is The program that You Are Missing Out on.
I raced out shopping as heinz said to look good. I thought black for remembrance. I was hugged by heinz and he said you look amazing. I do scrub up well. The kind sales assistants fitted me out nicely.
I used too look like the homeless I love and slept with. It's getting cold and snowing now.
But I play the super hero survivor, I have story after story. These very fine doctors lead by passion and integrity and curiosity. Somehow heinz brings them the best from USA. Some of the cream of the crop of ketogenic gurus .
For dessert I have a big everest cream and coffee. I take it to the speakers table and tell il2 crp basal temp stories of the mayo clinic and a clever oz scientist
I preach my gospel to all the conference speakers. They are enthused but one by one they drop off.
Until it's just Dr John, he is a gifted Dr and scientist . Humble and sincere. He asks perpetrating questions I explain it all. Again he listens. I share my joy of life in the science of my success.
Another top scientist listens and learns. It's late I'm the last one. Off to do enema, dressed to kill. Looking great and all alone in the junior suite. My cancer stories such a good pickup lines.
I'm tired enema and sleep.
But I do my 2nd shot il2 6000000units and some micro veda life
http://www.clinlabnavigator.com/carcinoembryonic-antigen-cea.html
See the report.
https://drive.google.com/file/d/0B10BiJHPKeH8VTNqUFUyRHk1QkNUWDlGa1BEUndMcDZYVk9V/view?usp=docslist_api
I have good talk Dr paccman about assessment. We do further tests focusing immune system. But these results excellent.
November 24-25, 2015, Concert Hall Felix Meritis, Keizersgracht 324, Amsterdam, The Netherlands
Home
Program
Information
Venue
Registration
Abstract
Sponsors
Program
Scientific Program
List of confirmed Speakers:
Stéphane Ascarateil, Paris, France
Roy Bicknell, Birmingham, United Kingdom
Tanja de Gruijl, Amsterdam, Netherlands
Elisabeth Huijbers, Amsterdam, Netherlands
Lars Hellman, Uppsala, Sweden
Lars Holmgren, Stockholm, Sweden
Yvette van Kooyk, Amsterdam, Netherlands
Lena Kranz, Mainz, Germany
Cornelis Melief, Leiden, Netherlands
Anna-Karin Olsson, Uppsala, Sweden
Michael Platten, Heidelberg, Germany
Jolanda de Vries, Nijmegen, Netherlands
Madelon Wentink, Amsterdam, Netherlands
Laurence Zitvogel, Paris, France
Click here for a printer friendly version of the program
Tuesday Afternoon, November 24th, 2015
13.30-14.00
Registration
14.00-14.15
Opening by Arjan Griffioen (Amsterdam)
Session 1
Vaccination strategies
Chair: Arjan Griffioen (Amsterdam, Netherlands)
14.15-14.45
Cornelis Melief
(Leiden, The Netherlands)
Treatment of cancer by therapeutic vaccines requires combination treatment
14.45-15.15
Stephane Ascarateil
(Paris, France)
Characteristics of adjuvants for therapeutic cancer vaccines
15.15-15.30
Frederica Ricardo
(Turin, Italy)
DNA vaccination against human
CSPG4 for the treatment of malignant
melanoma: a comparative oncology
trial in dog
15.30-16.00
Coffee/tea break
16.00-16.30
Lena Kranz
(Mainz, Germany)
A liposome-based vaccination platform for the treatment of cancer
16.30-16.45
Evelien Smits
(Antwerp, Belgium)
Vaccination with WT1 mRNA-
electroporated dendritic cells as
postremission treatment can avoid or
delay relapse in acute myeloid
leukemia: phase II study with 30 patients
16.45-17.00Rein Verbeke
(Ghent, Belgium)
Immunogenic mRNA nanoparticles for
dendritic cell-based cancer
vaccination
17.00-18.00
Opening mixer
.
Wednesday Morning, November 25th, 2015
Session 2
Vaccination targeting the vasculature
Chair: Anna-Karin Olsson, (Uppsala, Sweden)
09.00-09.30
Michael Platten
(Heidelberg, Germany)
Immunotherapeutic options for brain tumors
09.30-10.00
Anna-Karin Olsson
(Uppsala Sweden)
Targeting tumor vessels by therapeutic vaccination
10.00-10.30
Lars Holmgren
(Stockholm, Sweden)
Targeting novel endothelial junction proteins in cancer
10.30-11.00
Coffee Break
11.00-11.30
Elisabeth Huijbers
(Amsterdam, The Netherlands)
The quest for targets in the tumor vasculature – enhanced vaccination strategies
11.30-12.00
Roy Bicknell
(Birmingham, UK)
Robo4 vaccines induce antibodies that retard tumor growth
12.00-12.30
Madelon Wentink
(Amsterdam, The Netherlands)
hVEGF26-104/RFASE: An angiostatic vaccine targeting VEGF
12.30-13.45
Lunch
Wednesday Afternoon, November 25th, 2015
Session 3
Promising targets and adjuvants
Chair: Michael Platten (Heidelberg, Germany)
13.45-14.15
Yvette van Kooyk
(Amsterdam, The Netherlands)
Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines.
14.15-14.45
Lars Hellman
(Uppsala, Sweden)
Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters.
14.45-15.15
Laurence Zitvogel
(Paris, France)
Gut microbiome and cancer therapeutics: a new arena
15.15-15.45
Tea Break
15.45-16.15
Jolanda de Vries
(Nijmegen, Netherlands)
Harnessing adaptive immune responses in hereditary cancer
16.15-16.45
Tanja de Gruijl
(Amsterdam, The Netherlands)
Fighting local immune suppression – improving the odds for cancer vaccination
16.45-17.00
Sophie Dusoswa
(Amsterdam, The Netherlands)
Turning tumor glycans into anti-cancer
vaccines
17.00-17.15
Julia Femel
(Uppsala, Sweden)
A therapeutic cancer vaccine against
galectin-1
X's
